img

Global RNA Therapeutics Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global RNA Therapeutics Market Insights, Forecast to 2034

RNA therapeutics, also known as RNA-based therapeutics or RNA medicines, refer to a class of medical treatments that utilize RNA molecules to intervene in gene expression and regulation within cells. RNA (ribonucleic acid) is a vital molecule in cells responsible for various biological processes, including protein synthesis and gene regulation.
Market Analysis and InsightsGlobal RNA Therapeutics Market
Global RNA Therapeutics market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, RNA Therapeutics industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, RNA Therapeutics key companies include Moderna, Alnylam Pharmaceuticals, Novartis, Ionis Pharmaceuticals, Sarepta Therapeutics, Sanofi, Pfizer, Arrowhead Pharmaceuticals and BioNTech, etc. Moderna, Alnylam Pharmaceuticals, Novartis are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of RNA Therapeutics were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the share will be % in 2029. Moreover, China, plays a key role in the whole RNA Therapeutics market and estimated to attract more attentions from industry insiders and investors.
RNA Therapeutics can be divided into mRNA, RNA Interference (RNAi), Antisense Oligonucleotide (ASO) and Other, etc. mRNA is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2029.
RNA Therapeutics is widely used in various fields, such as Hospitals and Research Institutions, etc. Hospitals provides greatest supports to the RNA Therapeutics industry development. In 2022, global % revenue of RNA Therapeutics went into Hospitals filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global RNA Therapeutics market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global RNA Therapeutics market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Moderna
Alnylam Pharmaceuticals
Novartis
Ionis Pharmaceuticals
Sarepta Therapeutics
Sanofi
Pfizer
Arrowhead Pharmaceuticals
BioNTech
Orna Therapeutics
CRISPR Therapeutics
Silence Therapeutics
Astellas Pharma Inc.
CureVac
Sirnaomics
Arcturus Therapeutics
Arbutus Biopharma
Segment by Type
mRNA
RNA Interference (RNAi)
Antisense Oligonucleotide (ASO)
Other

Segment by Application


Hospitals
Research Institutions
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, RNA Therapeutics introduction, etc. RNA Therapeutics Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports’s Conclusions of RNA Therapeutics
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 mRNA
1.2.3 RNA Interference (RNAi)
1.2.4 Antisense Oligonucleotide (ASO)
1.2.5 Other
1.3 Market by Application
1.3.1 Global RNA Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Research Institutions
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNA Therapeutics Market Perspective (2018-2029)
2.2 Global RNA Therapeutics Growth Trends by Region
2.2.1 RNA Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 RNA Therapeutics Historic Market Size by Region (2018-2024)
2.2.3 RNA Therapeutics Forecasted Market Size by Region (2024-2029)
2.3 RNA Therapeutics Market Dynamics
2.3.1 RNA Therapeutics Industry Trends
2.3.2 RNA Therapeutics Market Drivers
2.3.3 RNA Therapeutics Market Challenges
2.3.4 RNA Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue RNA Therapeutics by Players
3.1.1 Global RNA Therapeutics Revenue by Players (2018-2024)
3.1.2 Global RNA Therapeutics Revenue Market Share by Players (2018-2024)
3.2 Global RNA Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of RNA Therapeutics, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global RNA Therapeutics Market Concentration Ratio
3.4.1 Global RNA Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA Therapeutics Revenue in 2022
3.5 Global Key Players of RNA Therapeutics Head office and Area Served
3.6 Global Key Players of RNA Therapeutics, Product and Application
3.7 Global Key Players of RNA Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 RNA Therapeutics Breakdown Data by Type
4.1 Global RNA Therapeutics Historic Market Size by Type (2018-2024)
4.2 Global RNA Therapeutics Forecasted Market Size by Type (2024-2029)
5 RNA Therapeutics Breakdown Data by Application
5.1 Global RNA Therapeutics Historic Market Size by Application (2018-2024)
5.2 Global RNA Therapeutics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America RNA Therapeutics Market Size (2018-2029)
6.2 North America RNA Therapeutics Market Size by Type
6.2.1 North America RNA Therapeutics Market Size by Type (2018-2024)
6.2.2 North America RNA Therapeutics Market Size by Type (2024-2029)
6.2.3 North America RNA Therapeutics Market Share by Type (2018-2029)
6.3 North America RNA Therapeutics Market Size by Application
6.3.1 North America RNA Therapeutics Market Size by Application (2018-2024)
6.3.2 North America RNA Therapeutics Market Size by Application (2024-2029)
6.3.3 North America RNA Therapeutics Market Share by Application (2018-2029)
6.4 North America RNA Therapeutics Market Size by Country
6.4.1 North America RNA Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America RNA Therapeutics Market Size by Country (2018-2024)
6.4.3 North America RNA Therapeutics Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe RNA Therapeutics Market Size (2018-2029)
7.2 Europe RNA Therapeutics Market Size by Type
7.2.1 Europe RNA Therapeutics Market Size by Type (2018-2024)
7.2.2 Europe RNA Therapeutics Market Size by Type (2024-2029)
7.2.3 Europe RNA Therapeutics Market Share by Type (2018-2029)
7.3 Europe RNA Therapeutics Market Size by Application
7.3.1 Europe RNA Therapeutics Market Size by Application (2018-2024)
7.3.2 Europe RNA Therapeutics Market Size by Application (2024-2029)
7.3.3 Europe RNA Therapeutics Market Share by Application (2018-2029)
7.4 Europe RNA Therapeutics Market Size by Country
7.4.1 Europe RNA Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe RNA Therapeutics Market Size by Country (2018-2024)
7.4.3 Europe RNA Therapeutics Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China RNA Therapeutics Market Size (2018-2029)
8.2 China RNA Therapeutics Market Size by Type
8.2.1 China RNA Therapeutics Market Size by Type (2018-2024)
8.2.2 China RNA Therapeutics Market Size by Type (2024-2029)
8.2.3 China RNA Therapeutics Market Share by Type (2018-2029)
8.3 China RNA Therapeutics Market Size by Application
8.3.1 China RNA Therapeutics Market Size by Application (2018-2024)
8.3.2 China RNA Therapeutics Market Size by Application (2024-2029)
8.3.3 China RNA Therapeutics Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia RNA Therapeutics Market Size (2018-2029)
9.2 Asia RNA Therapeutics Market Size by Type
9.2.1 Asia RNA Therapeutics Market Size by Type (2018-2024)
9.2.2 Asia RNA Therapeutics Market Size by Type (2024-2029)
9.2.3 Asia RNA Therapeutics Market Share by Type (2018-2029)
9.3 Asia RNA Therapeutics Market Size by Application
9.3.1 Asia RNA Therapeutics Market Size by Application (2018-2024)
9.3.2 Asia RNA Therapeutics Market Size by Application (2024-2029)
9.3.3 Asia RNA Therapeutics Market Share by Application (2018-2029)
9.4 Asia RNA Therapeutics Market Size by Region
9.4.1 Asia RNA Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia RNA Therapeutics Market Size by Region (2018-2024)
9.4.3 Asia RNA Therapeutics Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America RNA Therapeutics Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America RNA Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America RNA Therapeutics Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America RNA Therapeutics Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America RNA Therapeutics Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America RNA Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America RNA Therapeutics Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America RNA Therapeutics Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America RNA Therapeutics Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America RNA Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America RNA Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America RNA Therapeutics Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America RNA Therapeutics Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Moderna
11.1.1 Moderna Company Details
11.1.2 Moderna Business Overview
11.1.3 Moderna RNA Therapeutics Introduction
11.1.4 Moderna Revenue in RNA Therapeutics Business (2018-2024)
11.1.5 Moderna Recent Developments
11.2 Alnylam Pharmaceuticals
11.2.1 Alnylam Pharmaceuticals Company Details
11.2.2 Alnylam Pharmaceuticals Business Overview
11.2.3 Alnylam Pharmaceuticals RNA Therapeutics Introduction
11.2.4 Alnylam Pharmaceuticals Revenue in RNA Therapeutics Business (2018-2024)
11.2.5 Alnylam Pharmaceuticals Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis RNA Therapeutics Introduction
11.3.4 Novartis Revenue in RNA Therapeutics Business (2018-2024)
11.3.5 Novartis Recent Developments
11.4 Ionis Pharmaceuticals
11.4.1 Ionis Pharmaceuticals Company Details
11.4.2 Ionis Pharmaceuticals Business Overview
11.4.3 Ionis Pharmaceuticals RNA Therapeutics Introduction
11.4.4 Ionis Pharmaceuticals Revenue in RNA Therapeutics Business (2018-2024)
11.4.5 Ionis Pharmaceuticals Recent Developments
11.5 Sarepta Therapeutics
11.5.1 Sarepta Therapeutics Company Details
11.5.2 Sarepta Therapeutics Business Overview
11.5.3 Sarepta Therapeutics RNA Therapeutics Introduction
11.5.4 Sarepta Therapeutics Revenue in RNA Therapeutics Business (2018-2024)
11.5.5 Sarepta Therapeutics Recent Developments
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi RNA Therapeutics Introduction
11.6.4 Sanofi Revenue in RNA Therapeutics Business (2018-2024)
11.6.5 Sanofi Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer RNA Therapeutics Introduction
11.7.4 Pfizer Revenue in RNA Therapeutics Business (2018-2024)
11.7.5 Pfizer Recent Developments
11.8 Arrowhead Pharmaceuticals
11.8.1 Arrowhead Pharmaceuticals Company Details
11.8.2 Arrowhead Pharmaceuticals Business Overview
11.8.3 Arrowhead Pharmaceuticals RNA Therapeutics Introduction
11.8.4 Arrowhead Pharmaceuticals Revenue in RNA Therapeutics Business (2018-2024)
11.8.5 Arrowhead Pharmaceuticals Recent Developments
11.9 BioNTech
11.9.1 BioNTech Company Details
11.9.2 BioNTech Business Overview
11.9.3 BioNTech RNA Therapeutics Introduction
11.9.4 BioNTech Revenue in RNA Therapeutics Business (2018-2024)
11.9.5 BioNTech Recent Developments
11.10 Orna Therapeutics
11.10.1 Orna Therapeutics Company Details
11.10.2 Orna Therapeutics Business Overview
11.10.3 Orna Therapeutics RNA Therapeutics Introduction
11.10.4 Orna Therapeutics Revenue in RNA Therapeutics Business (2018-2024)
11.10.5 Orna Therapeutics Recent Developments
11.11 CRISPR Therapeutics
11.11.1 CRISPR Therapeutics Company Details
11.11.2 CRISPR Therapeutics Business Overview
11.11.3 CRISPR Therapeutics RNA Therapeutics Introduction
11.11.4 CRISPR Therapeutics Revenue in RNA Therapeutics Business (2018-2024)
11.11.5 CRISPR Therapeutics Recent Developments
11.12 Silence Therapeutics
11.12.1 Silence Therapeutics Company Details
11.12.2 Silence Therapeutics Business Overview
11.12.3 Silence Therapeutics RNA Therapeutics Introduction
11.12.4 Silence Therapeutics Revenue in RNA Therapeutics Business (2018-2024)
11.12.5 Silence Therapeutics Recent Developments
11.13 Astellas Pharma Inc.
11.13.1 Astellas Pharma Inc. Company Details
11.13.2 Astellas Pharma Inc. Business Overview
11.13.3 Astellas Pharma Inc. RNA Therapeutics Introduction
11.13.4 Astellas Pharma Inc. Revenue in RNA Therapeutics Business (2018-2024)
11.13.5 Astellas Pharma Inc. Recent Developments
11.14 CureVac
11.14.1 CureVac Company Details
11.14.2 CureVac Business Overview
11.14.3 CureVac RNA Therapeutics Introduction
11.14.4 CureVac Revenue in RNA Therapeutics Business (2018-2024)
11.14.5 CureVac Recent Developments
11.15 Sirnaomics
11.15.1 Sirnaomics Company Details
11.15.2 Sirnaomics Business Overview
11.15.3 Sirnaomics RNA Therapeutics Introduction
11.15.4 Sirnaomics Revenue in RNA Therapeutics Business (2018-2024)
11.15.5 Sirnaomics Recent Developments
11.16 Arcturus Therapeutics
11.16.1 Arcturus Therapeutics Company Details
11.16.2 Arcturus Therapeutics Business Overview
11.16.3 Arcturus Therapeutics RNA Therapeutics Introduction
11.16.4 Arcturus Therapeutics Revenue in RNA Therapeutics Business (2018-2024)
11.16.5 Arcturus Therapeutics Recent Developments
11.17 Arbutus Biopharma
11.17.1 Arbutus Biopharma Company Details
11.17.2 Arbutus Biopharma Business Overview
11.17.3 Arbutus Biopharma RNA Therapeutics Introduction
11.17.4 Arbutus Biopharma Revenue in RNA Therapeutics Business (2018-2024)
11.17.5 Arbutus Biopharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global RNA Therapeutics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of mRNA
Table 3. Key Players of RNA Interference (RNAi)
Table 4. Key Players of Antisense Oligonucleotide (ASO)
Table 5. Key Players of Other
Table 6. Global RNA Therapeutics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global RNA Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global RNA Therapeutics Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global RNA Therapeutics Market Share by Region (2018-2024)
Table 10. Global RNA Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global RNA Therapeutics Market Share by Region (2024-2029)
Table 12. RNA Therapeutics Market Trends
Table 13. RNA Therapeutics Market Drivers
Table 14. RNA Therapeutics Market Challenges
Table 15. RNA Therapeutics Market Restraints
Table 16. Global RNA Therapeutics Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global RNA Therapeutics Revenue Share by Players (2018-2024)
Table 18. Global Top RNA Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Therapeutics as of 2022)
Table 19. Global RNA Therapeutics Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by RNA Therapeutics Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of RNA Therapeutics, Headquarters and Area Served
Table 22. Global Key Players of RNA Therapeutics, Product and Application
Table 23. Global Key Players of RNA Therapeutics, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global RNA Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global RNA Therapeutics Revenue Market Share by Type (2018-2024)
Table 27. Global RNA Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global RNA Therapeutics Revenue Market Share by Type (2024-2029)
Table 29. Global RNA Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global RNA Therapeutics Revenue Share by Application (2018-2024)
Table 31. Global RNA Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global RNA Therapeutics Revenue Share by Application (2024-2029)
Table 33. North America RNA Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America RNA Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America RNA Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America RNA Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America RNA Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America RNA Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America RNA Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe RNA Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe RNA Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe RNA Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe RNA Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe RNA Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe RNA Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe RNA Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 47. China RNA Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 48. China RNA Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 49. China RNA Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 50. China RNA Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia RNA Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia RNA Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia RNA Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia RNA Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia RNA Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia RNA Therapeutics Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia RNA Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America RNA Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America RNA Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America RNA Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America RNA Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America RNA Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America RNA Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America RNA Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 65. Moderna Company Details
Table 66. Moderna Business Overview
Table 67. Moderna RNA Therapeutics Product
Table 68. Moderna Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 69. Moderna Recent Developments
Table 70. Alnylam Pharmaceuticals Company Details
Table 71. Alnylam Pharmaceuticals Business Overview
Table 72. Alnylam Pharmaceuticals RNA Therapeutics Product
Table 73. Alnylam Pharmaceuticals Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 74. Alnylam Pharmaceuticals Recent Developments
Table 75. Novartis Company Details
Table 76. Novartis Business Overview
Table 77. Novartis RNA Therapeutics Product
Table 78. Novartis Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 79. Novartis Recent Developments
Table 80. Ionis Pharmaceuticals Company Details
Table 81. Ionis Pharmaceuticals Business Overview
Table 82. Ionis Pharmaceuticals RNA Therapeutics Product
Table 83. Ionis Pharmaceuticals Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 84. Ionis Pharmaceuticals Recent Developments
Table 85. Sarepta Therapeutics Company Details
Table 86. Sarepta Therapeutics Business Overview
Table 87. Sarepta Therapeutics RNA Therapeutics Product
Table 88. Sarepta Therapeutics Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 89. Sarepta Therapeutics Recent Developments
Table 90. Sanofi Company Details
Table 91. Sanofi Business Overview
Table 92. Sanofi RNA Therapeutics Product
Table 93. Sanofi Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 94. Sanofi Recent Developments
Table 95. Pfizer Company Details
Table 96. Pfizer Business Overview
Table 97. Pfizer RNA Therapeutics Product
Table 98. Pfizer Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 99. Pfizer Recent Developments
Table 100. Arrowhead Pharmaceuticals Company Details
Table 101. Arrowhead Pharmaceuticals Business Overview
Table 102. Arrowhead Pharmaceuticals RNA Therapeutics Product
Table 103. Arrowhead Pharmaceuticals Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 104. Arrowhead Pharmaceuticals Recent Developments
Table 105. BioNTech Company Details
Table 106. BioNTech Business Overview
Table 107. BioNTech RNA Therapeutics Product
Table 108. BioNTech Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 109. BioNTech Recent Developments
Table 110. Orna Therapeutics Company Details
Table 111. Orna Therapeutics Business Overview
Table 112. Orna Therapeutics RNA Therapeutics Product
Table 113. Orna Therapeutics Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 114. Orna Therapeutics Recent Developments
Table 115. CRISPR Therapeutics Company Details
Table 116. CRISPR Therapeutics Business Overview
Table 117. CRISPR Therapeutics RNA Therapeutics Product
Table 118. CRISPR Therapeutics Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 119. CRISPR Therapeutics Recent Developments
Table 120. Silence Therapeutics Company Details
Table 121. Silence Therapeutics Business Overview
Table 122. Silence Therapeutics RNA Therapeutics Product
Table 123. Silence Therapeutics Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 124. Silence Therapeutics Recent Developments
Table 125. Astellas Pharma Inc. Company Details
Table 126. Astellas Pharma Inc. Business Overview
Table 127. Astellas Pharma Inc. RNA Therapeutics Product
Table 128. Astellas Pharma Inc. Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 129. Astellas Pharma Inc. Recent Developments
Table 130. CureVac Company Details
Table 131. CureVac Business Overview
Table 132. CureVac RNA Therapeutics Product
Table 133. CureVac Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 134. CureVac Recent Developments
Table 135. Sirnaomics Company Details
Table 136. Sirnaomics Business Overview
Table 137. Sirnaomics RNA Therapeutics Product
Table 138. Sirnaomics Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 139. Sirnaomics Recent Developments
Table 140. Arcturus Therapeutics Company Details
Table 141. Arcturus Therapeutics Business Overview
Table 142. Arcturus Therapeutics RNA Therapeutics Product
Table 143. Arcturus Therapeutics Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 144. Arcturus Therapeutics Recent Developments
Table 145. Arbutus Biopharma Company Details
Table 146. Arbutus Biopharma Business Overview
Table 147. Arbutus Biopharma RNA Therapeutics Product
Table 148. Arbutus Biopharma Revenue in RNA Therapeutics Business (2018-2024) & (US$ Million)
Table 149. Arbutus Biopharma Recent Developments
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global RNA Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global RNA Therapeutics Market Share by Type: 2022 VS 2029
Figure 3. mRNA Features
Figure 4. RNA Interference (RNAi) Features
Figure 5. Antisense Oligonucleotide (ASO) Features
Figure 6. Other Features
Figure 7. Global RNA Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global RNA Therapeutics Market Share by Application: 2022 VS 2029
Figure 9. Hospitals Case Studies
Figure 10. Research Institutions Case Studies
Figure 11. RNA Therapeutics Report Years Considered
Figure 12. Global RNA Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global RNA Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global RNA Therapeutics Market Share by Region: 2022 VS 2029
Figure 15. Global RNA Therapeutics Market Share by Players in 2022
Figure 16. Global Top RNA Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Therapeutics as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by RNA Therapeutics Revenue in 2022
Figure 18. North America RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America RNA Therapeutics Market Share by Type (2018-2029)
Figure 20. North America RNA Therapeutics Market Share by Application (2018-2029)
Figure 21. North America RNA Therapeutics Market Share by Country (2018-2029)
Figure 22. United States RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe RNA Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe RNA Therapeutics Market Share by Type (2018-2029)
Figure 26. Europe RNA Therapeutics Market Share by Application (2018-2029)
Figure 27. Europe RNA Therapeutics Market Share by Country (2018-2029)
Figure 28. Germany RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China RNA Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China RNA Therapeutics Market Share by Type (2018-2029)
Figure 36. China RNA Therapeutics Market Share by Application (2018-2029)
Figure 37. Asia RNA Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia RNA Therapeutics Market Share by Type (2018-2029)
Figure 39. Asia RNA Therapeutics Market Share by Application (2018-2029)
Figure 40. Asia RNA Therapeutics Market Share by Region (2018-2029)
Figure 41. Japan RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America RNA Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America RNA Therapeutics Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America RNA Therapeutics Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America RNA Therapeutics Market Share by Country (2018-2029)
Figure 51. Brazil RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries RNA Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Moderna Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 58. Alnylam Pharmaceuticals Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 59. Novartis Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 60. Ionis Pharmaceuticals Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 61. Sarepta Therapeutics Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 62. Sanofi Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 63. Pfizer Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 64. Arrowhead Pharmaceuticals Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 65. BioNTech Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 66. Orna Therapeutics Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 67. CRISPR Therapeutics Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 68. Silence Therapeutics Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 69. Astellas Pharma Inc. Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 70. CureVac Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 71. Sirnaomics Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 72. Arcturus Therapeutics Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 73. Arbutus Biopharma Revenue Growth Rate in RNA Therapeutics Business (2018-2024)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries